Quest Diagnostics Inc vs Rockwell Automation — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Rockwell Automation trades at $450 (market cap $49.64B). The key difference: Rockwell Automation is the larger of the two by market cap, and Quest Diagnostics Inc pays the higher dividend (1.45%). Which is the better fit depends on your goals.
| DGX | ROK | |
|---|---|---|
Market Cap | $26.21B | $49.64B |
Sector | Health | Industrials |
52-Week High | $238.50 | $495.08 |
52-Week Low | $173.49 | $333.75 |
Enterprise Value | $31.97B | $52.77B |
Dividend Yield | 1.45% | 1.23% |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →